单位:[1]China Japan Friendship Hosp, Dept Oncol Integrated Tradit Chinese & Western Med, Beijing, Peoples R China[2]Beijing Univ Chinese Med, Grad Sch, Beijing, Peoples R China[3]Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands[4]Hunan Univ Chinese Med, Coll Pharm, Changsha, Peoples R China[5]Beijing Univ Chinese Med, Coll Tradit Chinese Med, Beijing, Peoples R China
BackgroundCancer is a leading cause of death in the world, and the estimated new cancer cases were 19 million and the estimated cancer deaths were around 10 million worldwide in 2020. Proton therapy (PT) is a promising treatment for cancers; however, only few patients with cancer received PT due to limited number of PT centers worldwide, especially in low- and middle-income countries. Methods and ResultsCross-sectional country level data were collected from publicly available information. Lorenz curves and Gini coefficient were used to assess the inequality in accessing to PT, and zero-inflated Poisson models were used to investigate the determinants of number of PT facilities in each country. The Gini coefficients were 0.96 for PT centers and 0.96 for PT chambers, which indicated high level of inequality. Total GDP had a significant impact on whether a country had a practical PT center, whereas total GDP and GDP per capita had significant impacts on the number of PT centers. ConclusionExtremely high inequality exists in accessibility of PT centers among all countries in the world. Economic development was the most important factor determining the adoption of PT; thus, with the growth in global economics, more PT centers can be expected in near future.
第一作者单位:[1]China Japan Friendship Hosp, Dept Oncol Integrated Tradit Chinese & Western Med, Beijing, Peoples R China[2]Beijing Univ Chinese Med, Grad Sch, Beijing, Peoples R China
通讯作者:
推荐引用方式(GB/T 7714):
Xia Zhongying,Wang Junfeng,Xia Jiaxin,et al.Inequality in Accessibility of Proton Therapy for Cancers and Its Economic Determinants: A Cross-Sectional Study[J].FRONTIERS in ONCOLOGY.2022,12:doi:10.3389/fonc.2022.876368.
APA:
Xia, Zhongying,Wang, Junfeng,Xia, Jiaxin,Wang, Menglei&Cheng, Zhiqiang.(2022).Inequality in Accessibility of Proton Therapy for Cancers and Its Economic Determinants: A Cross-Sectional Study.FRONTIERS in ONCOLOGY,12,
MLA:
Xia, Zhongying,et al."Inequality in Accessibility of Proton Therapy for Cancers and Its Economic Determinants: A Cross-Sectional Study".FRONTIERS in ONCOLOGY 12.(2022)